Abstract
Testing circulating cell free fetal RNA in maternal plasma is currently the most promising approach for noninvasive trisomy 21 detection. The method involves measuring the ratios of heterozygous SNPs on fetal RNA. In this study, 10samples were used to assess an alternative technical strategy using epigenetic (methylation) markers to distinguish and enrich fetal DNA for aneuploidy testing.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have